Elite members get real-time data, technical charting, alerts, and no ads - starting at $24.96/mo. Try Elite Free for 7 Days
Login Sign up free
Home Screener Maps Charts News Groups Insider Futures Forex Crypto Portfolio Calendar
Pricing

New feature:   Introducing the Finviz Matrix

Learn More
Market News Market Pulse Stocks News ETF News Crypto News

MediWound Ltd.

Contributing Author

Recent Articles by MediWound Ltd.

Sep-02
MediWound to Present at the H.C. Wainwright 28th Annual Global Investment Conference MDWD GlobeNewswire
Aug-13
MediWound Reports Second Quarter 2026 Financial Results and Provides Corporate Update MDWD GlobeNewswire
Jul-29
MediWound to Report Second Quarter 2026 Financial Results MDWD GlobeNewswire
May-27
MediWound Reports First Quarter 2026 Financial Results and Provides Corporate Update MDWD -14.09% GlobeNewswire
May-07
MediWound to Report First Quarter 2026 Financial Results MDWD GlobeNewswire
Apr-13
Newly Published U.S. Expert Consensus Aligns with MediWound's Strategy for Chronic Wound Debridement MDWD GlobeNewswire
Apr-07
MediWound to Present New EscharEx Data at Leading Wound Care Conferences MDWD GlobeNewswire
Apr-02
MediWound Reports BARDA Contract Award to Vericel for NexoBrid Valued at up to $197 Million MDWD GlobeNewswire
Mar-05
MediWound Files Annual Report on Form 20-F MDWD GlobeNewswire
Mar-05
MediWound Reports Fourth Quarter and Full Year 2025 Financial Results MDWD GlobeNewswire
Feb-19
MediWound to Report Fourth Quarter and Full Year 2025 Financial Results MDWD GlobeNewswire
Feb-17
MediWound to Present at Upcoming Investor Conferences MDWD GlobeNewswire
Jan-12
MediWound Provides Corporate Update and Financial Outlook Ahead of the J.P. Morgan Healthcare Conference MDWD -7.86% GlobeNewswire
Dec-10
MediWound Reports New Clinical Data Demonstrating NexoBrid's Effectiveness in Preventing Traumatic Tattoos After Abrasion and Blast Injuries MDWD GlobeNewswire
Nov-20
MediWound Reports Third Quarter 2025 Financial Results and Provides Corporate Update MDWD -5.60% GlobeNewswire
Nov-05
MediWound to Report Third Quarter 2025 Financial Results MDWD GlobeNewswire
Nov-03
MediWound Successfully Completes Commissioning of Expanded GMP Manufacturing Facility for NexoBrid MDWD GlobeNewswire
Sep-29
MediWound Announces $30 Million Registered Direct Offering of Ordinary Shares MDWD GlobeNewswire
Sep-25
MediWound Expands Global Reach with Marketing Approval of NexoBrid in Australia MDWD GlobeNewswire
Sep-02
MediWound's NexoBrid to be Highlighted in 36 Scientific Presentations at the 21st European Burns Association Congress MDWD GlobeNewswire
Aug-20
MediWound to Present at the H.C. Wainwright 27th Annual Global Investment Conference MDWD GlobeNewswire
Aug-14
MediWound Reports Second Quarter 2025 Financial Results and Provides Corporate Update MDWD GlobeNewswire
Aug-13
MediWound Announces New EscharEx Phase II Data Demonstrating Strong Link Between Wound Bed Preparation and Wound Closure in Venous Leg Ulcers MDWD GlobeNewswire
Aug-04
MediWound to Report Second Quarter 2025 Financial Results MDWD GlobeNewswire
May-21
MediWound Reports First Quarter 2025 Financial Results and Provides Corporate Update MDWD GlobeNewswire
May-13
MediWound Announces Publication of Phase II EscharEx Data Demonstrating Superiority Over Collagenase in Venous Leg Ulcers MDWD +6.81% GlobeNewswire
May-05
MediWound to Report First Quarter 2025 Financial Results MDWD GlobeNewswire
Affiliate • Advertise • API and Exports • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information
Stock quotes delayed by 1 minute. Futures and options delayed by 15 minutes.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)